BSX241115C65000
- 21.71
- -1.89-8.01%
Boston Scientific Newsroom
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Bank of America Securities Keeps Their Buy Rating on Boston Scientific (BSX)
CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $98 to $100
Boston Scientific Analyst Ratings
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Boston Scientific (BSX) Gets a Buy From Bank of America Securities
C.L. King Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Argus Adjusts Price Target on Boston Scientific to $105 From $90
Baird Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Boston Scientific Price Target Maintained With a $98.00/Share by Canaccord Genuity
Boston Scientific Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $97 to $100
Boston Scientific Analyst Ratings
Mizuho Maintains Outperform on Boston Scientific, Raises Price Target to $110
Analysts Offer Insights on Healthcare Companies: Community Health (CYH), Viking Therapeutics (VKTX) and Boston Scientific (BSX)